 Braxia Scientific Corp. CSE:BRAX, OTC:BRAXF said that its scientists continue to carry out multiple psychedelic-based clinical research trials, adding to the companys large and growing proprietary dataset critical to informing future drug development. To date, Braxia Scientific has compiled comprehensive health data from administering more than 5,200 ketamine treatments at its network of clinics. 